ClinVar Miner

Submissions for variant NM_032043.3(BRIP1):c.1543del (p.Glu515fs)

dbSNP: rs1064793812
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000484034 SCV000567100 pathogenic not provided 2018-09-19 criteria provided, single submitter clinical testing This deletion of one nucleotide in BRIP1 is denoted c.1543delG at the cDNA level and p.Glu515LysfsX11 (E515KfsX11) at the protein level. The normal sequence, with the base that is deleted in brackets, is AAGA[delG]AAGT. The deletion causes a frameshift which changes a Glutamic Acid to a Lysine at codon 515, and creates a premature stop codon at position 11 of the new reading frame. Although this variant has not, to our knowledge, been reported in the literature, it is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. Based on currently available evidence, we consider this deletion to be pathogenic.
Invitae RCV002526540 SCV003346692 pathogenic Familial cancer of breast; Fanconi anemia complementation group J 2023-11-22 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Glu515Lysfs*11) in the BRIP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BRIP1 are known to be pathogenic (PMID: 16116423, 17033622, 21964575). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with BRIP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 419356). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Myriad Genetics, Inc. RCV003335351 SCV004045125 pathogenic Familial cancer of breast 2023-06-02 criteria provided, single submitter clinical testing This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.
Baylor Genetics RCV003335351 SCV004211376 likely pathogenic Familial cancer of breast 2021-06-04 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.